The Worldwide Viral Vectors and Plasmid DNA Manufacturing Industry is Expected to Reach $2.7 Billion by 2027
August 25, 2022 04:58 ET
|
Research and Markets
Dublin, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The "Global Viral Vectors and Plasmid DNA Manufacturing Market (2022-2027) by Product Type, Application, Geography, Competitive Analysis and the Impact of...
Global Gene Therapy Market Report 2022: Amid the COVID-19 Crisis, the Market is Projected to Reach a Revised Size of $2.7 Billion by 2026
August 19, 2022 05:08 ET
|
Research and Markets
Dublin, Aug. 19, 2022 (GLOBE NEWSWIRE) -- The "Gene Therapy - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Gene Therapy Market to...
Global Gene Therapy Market 2022-2027: Rising Funding for Gene Therapy Research Boosting Sector
August 12, 2022 04:43 ET
|
Research and Markets
Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Global Gene Therapy Market by Vectors (Non-viral(Oligonucleotides), Viral(Retroviral, Adeno-associated)), Indication (Cancer, Neurological,...
Global Viral Vector & Plasmid DNA Manufacturing Market Report to 2027 - Featuring ABL, Biovian and GE Healthcare Among Others
July 28, 2022 06:13 ET
|
Research and Markets
Dublin, July 28, 2022 (GLOBE NEWSWIRE) -- The "Viral Vector & Plasmid DNA Manufacturing Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's...
Avid Bioservices Reports Financial Results for Fourth Quarter and Full Fiscal Year Ended April 30, 2022 and Recent Developments
June 29, 2022 16:05 ET
|
Avid Bioservices, Inc
-- Recorded Fourth Quarter and Full Fiscal Year Revenue of $31 Million and $120 Million, Respectively -- -- Signed $44 Million in Net New Business Orders and Ended the Quarter with a Record High...
AGC Biologics Named Manufacturing Company of the year by American Business Awards
June 29, 2022 09:09 ET
|
AGC Biologics
SEATTLE, June 29, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it was named Company of the...
$12 Billion Worldwide Gene Therapy Industry to 2031 - Identify Growth Segments for Investment
June 23, 2022 05:38 ET
|
Research and Markets
Dublin, June 23, 2022 (GLOBE NEWSWIRE) -- The "Gene Therapy Global Market Report 2022, Vector, Application, End Users" report has been added to ResearchAndMarkets.com's offering. This report...
Global Gene Therapy Market Report 2022: A $21.25 Billion Market in 2026 - Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F
June 20, 2022 04:33 ET
|
Research and Markets
Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Gene Therapy Global Market Report 2022: By Gene, By Vector, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering. ...
Avid Bioservices Announces Launch of Analytical and Process Development Suites Within New, World-Class Viral Vector Development and Manufacturing Facility
June 14, 2022 08:05 ET
|
Avid Bioservices, Inc
AD/PD Laboratories Open Exactly Eight Months After Announced Plans to Build Viral Vector Facility Build-Out of Facility’s CGMP Manufacturing Suites Continues, Expected to Come Online in...
Global Cell and Gene Therapy Markets, Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F
May 30, 2022 05:58 ET
|
Research and Markets
Dublin, May 30, 2022 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Global Market Report 2022: By Product, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering. ...